Coherus BioSciences (NASDAQ:CHRS) is set to give its latest quarterly earnings report on Monday, 2026-03-09. Here’s what investors need to know before the announcement.
Analysts estimate that Coherus BioSciences will report an earnings per share (EPS) of $-0.34.
Investors in Coherus BioSciences are eagerly awaiting the company’s announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It’s worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
Earnings History Snapshot
In the previous earnings release, the company missed EPS by $0.01, leading to a 10.07% drop in the share price the following trading session.
Here’s a look at Coherus BioSciences’s past performance and the resulting price change:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.32 | -0.26 | -0.13 | -0.13 |
| EPS Actual | -0.33 | -0.34 | -0.35 | -0.28 |
| Price Change % | -10.07 | -7.13 | -19.11 | 0.96 |
Tracking Coherus BioSciences’s Stock Performance
Shares of Coherus BioSciences were trading at $1.76 as of March 05. Over the last 52-week period, shares are up 68.75%. Given that these returns are generally …